Lulilab Cream contains Luliconazole 1% w/w, an imidazole antifungal agent indicated for the topical treatment of superficial fungal infections such as dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, leading to increased membrane permeability and ultimately fungal cell death. This cream is effective against a broad spectrum of dermatophytes including Trichophyton rubrum and Trichophyton mentagrophytes, as well as yeasts like Candida species and Malassezia furfur. Lulilab Cream is applied once daily to the affected area and surrounding skin after cleansing and drying, typically for a duration of 2 to 4 weeks depending on the infection type and clinical response. It is well tolerated with minimal adverse effects, which may include mild local irritation, burning sensation, or erythema at the application site. Use of Lulilab Cream should be avoided in patients with known hypersensitivity to luliconazole or any formulation excipients. Proper adherence to the prescribed regimen is essential to prevent recurrence and promote complete resolution of infection. Consult a healthcare professional before use in pregnant or lactating women.